I. Abrunhosa et al. / Tetrahedron 60 (2004) 9263–9272
9269
3.3. Preparation of 2-pyridyl thiazoline 3d
7.3 Hz, CHN), 7.31 (dd, 1H, JZ8.3, 4.2 Hz, H3), 7.57 (dd,
1H, JZ8.1, 7.5 Hz, H6), 7.77 (d, 1H, JZ8.1 Hz, H5), 8.04
(dd, 1H, JZ8.3, 1.7 Hz, H4), 8.25 (d, 1H, JZ7.4 Hz, H7),
8.90 (dd, 1H, JZ4.2, 1.7 Hz, H2). 13C NMR (62.9 MHz,
CDCl3): 11.5 (CH3CH2), 28.4 (CH2CH3), 38.6 (CH2S), 77.9
(CHN), 121.7, 126.4, 128.6, 130.8, 130.8, 133.0, 136.7,
145.9, 150.1, 165.5 (S–C]N). IR (KBr): 2960, 2920, 1650
(nC]N), 1570, 1490, 1460, 1380, 1310, 1250. Calcd for
C14H14N2S: C, 69.39; H, 5.82; N, 11.56. Found: C, 69.93;
H, 5.52; N, 11.17.
Thiazoline 3d has been prepared using the general
procedure described for the 2-pyridyl thiazolines,3 in two
steps, starting from methyl pyridine-2-dithiocarboxylate8
and S-tert-leucinol. It was purified by silica gel flash
chromatography (pentane/diethyl ether: 70/30).
3.3.1. 2-[(S)-4,5-dihydro-4-tert-butyl-2-thiazolyl]pyri-
dine 3d. Yellow solid, mp 44 8C, [a]2D0ZK51 (c 1,
acetone), overall yieldZ81%. 1H NMR (400 MHz,
CDCl3): 1.08 (s, 9H, (CH3)3C), 3.21 (dd, 1H, JZ11.0,
10.4 Hz, CHHS), 3.33 (dd, 1H, JZ11.0, 9.3 Hz, CHHS),
4.46 (dd, 1H, JZ10.4, 9.3 Hz, CHN), 7.37 (dd, 1H, JZ7.7,
4.9 Hz, H4), 7.77 (dt, 1H, JZ7.7, 1.4 Hz, H5), 8.13 (d, 1H,
3.5.2. 8-[(S)-4,5-Dihydro-4-isopropyl-2-thiazolyl]quino-
line 5b. Brown solid, mp 55 8C, [a]2D0ZK141 (c 1,
acetone), overall yieldZ81%. 1H NMR (400 MHz,
CDCl3): 1.15 (d, 6H, JZ6.8 Hz, CH(CH3)2), 2.22 (sept,
1H, JZ6.8 Hz, CH(CH3)2), 3.14 (t, 1H, JZ10.7 Hz,
CHHS), 4.43 (dd, 1H, JZ10.7, 8.6 Hz, CHHS), 4.45 (ddd,
1H, JZ10.4, 8.6, 6.8 Hz, CH]N), 7.46 (dd, 1H, JZ8.3,
4.2 Hz, H3), 7.60 (dd, 1H, JZ8.1, 7.3 Hz, H6), 7.92 (d, 1H,
JZ8.1, 1.4 Hz, H5), 8.21 (dd, 1H, JZ8.3, 1.8 Hz, H4), 8.38
(dd, 1H, JZ7.3, 1.4 Hz, H7), 9.03 (dd, 1H, JZ4.2, 1.8 Hz,
H2). 13C NMR (62.9 MHz, CDCl3): 19.4, 20.3 ((CH3)2CH),
33.6 (CH2S), 36.3 (CH(CH3)2), 82.2 (CHN), 121.7, 126.5,
128.6, 130.7, 130.7, 133.2, 136.6, 146.0, 150.1, 165.5 (S–
C]N). IR (KBr): 2970, 2850, 1610 (nS–C]N), 1550, 1490,
1460, 1380, 1310, 1250. Calcd for C15H16N2S: C, 70.27; H,
6.29; N, 10.93. Found: C, 70.32; H, 6.29; N, 11.12.
3
JZ7.7 Hz, H6), 8.65 (dd, 1H, JZ4.9, 1.4 Hz, H3). 13C
NMR (62.9 MHz, CDCl3): 27.2 ((CH3)3C), 33.4 (CH2S),
35.8 ((CH3)3C), 88.8 (CHN), 122.0, 125.6, 136.7, 149.6,
151.8, 177.9 (SC]N) IR (NaCl): 2950, 2870, 1610 (nC]N),
1460, 1380, 1270. Anal. Calcd for C12H16N2S: C, 65.41; H,
7.32; N, 12.71; S, 14.55. Found: C, 65.08; H, 7.40; N, 12.42;
S, 14.33.
3.4. Preparation of pyridine-2,6-bis(thiazoline) 12b
Thiazoline 12b has been prepared using the general method
already described for analogous compounds with RZtBu,
Ph,3 in two steps, starting from dimethyl 2,6-pyridine
bis(dithiocarboxylate)8 and two equivalents of S-valinol. It
was purified by silica gel flash chromatography (pentane/
diethyl ether).
3.5.3. 8-[(S)-4,5-Dihydro-4-tert-butyl-2-thiazolyl]quino-
line 5d. Brown solid, mp 75 8C, [a]2D0ZK157 (c 1,
1
acetone), overall yieldZ85%. H NMR (400 M1H NMR
(400 MHz, CDCl3): 1.12 (s, 9H, (CH3)3C), 3.11 (t, 1H, JZ
11.5 Hz, CHHS), 3.34 (dd, 1H, JZ11.5, 8.7 Hz, CHHS),
4.34 (dd, 1H, JZ11.5, 8.7 Hz, CHN), 7.43 (dd, 1H, JZ8.3,
4.2 Hz, H3), 7.57 (dd, 1H, JZ8.1, 7.4 Hz, H6), 7.89 (dd, 1H,
JZ8.1, 1.2 Hz, H5), 8.16 (dd, 1H, JZ8.3, 1.7 Hz, H4), 8.38
(dd, 1H, JZ7.4, 1.2 Hz, H7), 8.99 (dd, 1H, JZ4.2, 1.7 Hz,
H2). 13C NMR (62.9 MHz, CDCl3): 27.5 ((CH3)3C), 35.1
(CH2S), 35.6 (C(CH3)3), 85.8 (CHN), 121.7, 126.5, 128.6,
130.8, 130.7, 133.2, 136.7, 146.0, 150.0, 165.2 (S–C]N).
IR (KBr): 2970, 2850, 1610 (nS–C]N), 1520, 1490, 1380,
1310, 1250. Mass m/z: 270 (MC, 6), 213 (100), 155 (16),
128 (7), 101 (5), 59 (8). Calcd for C16H18N2S: C, 71.07; H,
6.71; N, 10.36; S, 11.86. Found: C, 70.76; H, 6.89; N, 10.10;
S, 11.49.
3.4.1. 2,6-Bis[(S)-4,5-dihydro-4-isopropyl-2-thiazolyl]-
pyridine 12b. Yellow solid, mp 190 8C, [a]2D0ZK125 (c
1, acetone), overall yieldZ61%. 1H NMR (400 MHz,
CDCl3): 1.08 (t, 12H, JZ6.7, Hz, 2!CH(CH3)2), 2.13
(oct, 2H, JZ6.7 Hz, 2!CH(CH3)2), 3.11 (t, 2H, JZ
10.4 Hz, 2!CHHS), 3.38 (dd, 2H, JZ10.4, 9.3 Hz, 2!
CHHS), 4.53 (ddd, 2H, JZ10.4, 9.3, 6.7 Hz, 2!CHN), 7.83
(t, 1H, JZ7.7 Hz, H4), 8.16 (d, 2H, JZ7.7 Hz, H4 and H5).
13C NMR (62.9 MHz, CDCl3): 19.4 and 19.7 (2!
(CH3)2CH), 33.4 (2!CH(CH3)2), 34.1 (2!CH2S), 84.0
(2!CHN), 122.7, 136.9, 150.6, 167.9 (S–C]N). IR (KBr):
2960, 2870, 1600 (nS–CZN), 1450, 1360, 1310, 1020. Calcd
for C17H23N3S2: C, 61.22; H, 6.95; N, 12.60. Found: C,
60.91; H, 6.92; N, 12.78.
3.5. Preparation of 8-quinolyl thiazolines 5
3.5.4. 8-[(R)-4,5-Dihydro-4-phenyl-2-thiazolyl]quinoline
5f. Orange solid, mp 62 8C, [a]2D0ZK3.1 (c 1, acetone),
overall yieldZ82%. H NMR (400 MHz, CDCl3): 3.29 (t,
1
The 8-quinolyl thiazolines 5a,b,d,f have been prepared
using the general procedure described for the 2-quinolyl
thiazolines 43, in two steps, starting from dithioester 138 and
the corresponding aminoalcohol (R-2-aminobutanol,
S-valinol, S-tert-leucinol and, respectively, R-phenylglyci-
nol). They were purified by silica gel flash chromatography
(pentane/diethyl ether: 70/30).
1H, JZ10.9 Hz, CHHS), 3.81 (dd, 1H, JZ10.9, 8.7 Hz,
CHHS), 5.70 (dd, 1H, JZ10.9, 8.7 Hz, CHN), 7.24–7.54
(m, 6H, H3 and C6H5), 7.62 (dd, 1H, JZ8.0, 7.4 Hz, H6),
7.94 (dd, 1H, JZ8.0, 1.3 Hz, H5), 8.21 (dd, 1H, JZ8.3,
1.7 Hz, H4), 8.52 (dd, 1H, JZ7.4, 1.3 Hz, H7), 9.03 (dd, 1H,
JZ4.2, 1.7 Hz, H2). 13C NMR (62.9 MHz, CDCl3): 42.0
(CH2S), 78.7 (CHN), 121.8, 126.5, 127.2, 127.8, 128.7,
129.0, 131.0, 131.1, 132.6, 136.8, 142.9, 145.9, 150.1, 167.6
(C]N). IR (KBr): 1650 (nS–C]N), 1610, 1510, 1490, 1380,
1310, 1250. HRMS (MHC) calcd for C18H15N2S: 291.0956.
Found: 291.0951. Calcd for C18H14N2S: C, 74.45; H, 4.86;
N, 9.65; S, 11.04. Found: C, 73.73; H, 4.75; N, 9.60; S,
11.04.
3.5.1. 8-[(R)-4,5-Dihydro-4-ethyl-2-thiazolyl]quinoline
5a. Viscous dark red oil, [a]2D0ZC138 (c 1, acetone),
1
overall yieldZ79%. H NMR (400 MHz, CDCl3): 1.13 (t,
3H, JZ7.3 Hz, CH3CH2), 1.74 (m, 1H, CH2CH3), 1.92 (m,
1H, CH2CH3), 3.07 (dd, 1H, JZ10.8, 9.0 Hz, CHHS), 3.48
(dd, 1H, JZ10.8, 8.5 Hz, CHHS), 4.56 (dt, 1H, JZ8.5,